placeholder image
R. Shanley All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. 
    International Journal of Radiation Oncology, Biology, Physics. 2020
  • Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). 
    BMC cancer. 2020
  • Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. 
    Neuro-Oncology. 2020
  • Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. 
    Journal of Clinical Oncology. 2020
  • Estimating survival in patients with gastrointestinal cancers and brain metastases: an update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
    2019
  • Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?. 
    Translational Research: The Journal of Laboratory and Clinical Medicine. 2019
  • Effect of targeted therapies on prognostic factors, patterns of care, and survival in patients with renal cell carcinoma and brain metastases. 
    International Journal of Radiation Oncology, Biology, Physics. 2018
  • Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. 
    Neuro-Oncology. 2018
  • Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (melanoma-molGPA). 
    International Journal of Radiation Oncology, Biology, Physics. 2017
  • Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA). 
    JAMA oncology. 2017
  • The prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases. 
    International Journal of Radiation Oncology, Biology, Physics. 2017
  • The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases. 
    International Journal of Radiation Oncology, Biology, Physics. 2016
    • Contact
    full name
  • R. Shanley
    • Quick Info
     
    Collaboration